Abstract
The incorporation of information on genetic testing into the product label of the anticoagulant warfarin and the FDA marketing clearance for an associated test represent a significant advance for the field of pharmacogenetics.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Ontology-based disease similarity network for disease gene prediction
Vietnam Journal of Computer Science Open Access 16 March 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Jones, D. Steps on the road to personalized medicine. Nat Rev Drug Discov 6, 770–771 (2007). https://doi.org/10.1038/nrd2434
Issue Date:
DOI: https://doi.org/10.1038/nrd2434
This article is cited by
-
Ontology-based disease similarity network for disease gene prediction
Vietnam Journal of Computer Science (2016)
-
First oral warfarin alternative approved in the US
Nature Reviews Drug Discovery (2010)
-
2007: Spotlight on drug safety
Nature Reviews Drug Discovery (2008)
-
Assessing the Value-Adding Impact of Diagnostic-Type Tests on Drug Development and Marketing
Molecular Diagnosis & Therapy (2008)
